Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Background: Carbapenems (ertapenem, imipenem, meropenem) are used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB), even if the published evidence is limited, particularly when it is otherwise difficult to identify the recommended four active drugs to be inclu...

Full description

Bibliographic Details
Main Authors: Giovanni Sotgiu, Lia D’Ambrosio, Rosella Centis, Simon Tiberi, Susanna Esposito, Simone Dore, Antonio Spanevello, Giovanni Battista Migliori
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:International Journal of Molecular Sciences
Subjects:
MDR-TB
XDR-TB
carbapenems
imipenem
meropenem
ertapenem
effectiveness
safety
tolerability
Online Access:http://www.mdpi.com/1422-0067/17/3/373

Internet

http://www.mdpi.com/1422-0067/17/3/373

Similar Items